New Peptide Vaccines for Fighting Cancer
This patent describes new protein fragments, called polypeptides, designed to help the body's immune system fight specific cancers like lung, stomach, and skin cancer.
Patent Number
US 12734225
Status
Active
Filing Date
May 2, 2023
Grant Date
September 15, 2026
Expiration
~May 2043 (estimated)
Claims
0
Assignee
—
Inventors
—
Citations
0 forward · 0 backward
What it covers
The patent covers specific protein pieces, or polypeptides, that are designed to trigger a strong immune response against cancer cells. These peptides contain parts, known as T cell epitopes, that are recognized by the immune system's T cells. The goal is to teach the T cells to attack and destroy cancer cells, particularly in cancers like gastric cancer, lung cancer, melanoma, and bladder cancer. The patent also mentions using these peptides in pharmaceutical compositions, meaning they are formulated into medicines, and suggests methods for identifying patients who would benefit most from this treatment.
What it doesn't cover
- —Does not cover vaccines for infectious diseases like the flu or COVID-19.
- —Does not cover general cancer treatments that don't use specific T cell epitopes.
- —Does not cover diagnostic methods unrelated to identifying patients for peptide vaccine treatment.
- —Does not cover the use of whole proteins or DNA/RNA in the vaccine formulation.
- —Does not cover treatments for cancers not listed in the patent, such as brain tumors or leukemia.
The clever bit
The key innovation lies in identifying specific T cell epitopes within fusion peptides that are highly immunogenic, meaning they reliably provoke a strong immune response across a large percentage of patients, making the vaccine potentially more effective for a broader population.
Why it matters
Developing new ways to harness the immune system to fight cancer is a major focus in medicine. This patent represents a specific approach to cancer immunotherapy, aiming to create vaccines that are effective against a range of common and difficult-to-treat cancers.
Real-world examples
- 1.Potential cancer vaccines for lung cancer
- 2.Potential cancer vaccines for melanoma
- 3.Potential cancer vaccines for gastric cancer
- 4.Potential cancer vaccines for bladder cancer
Generated by PatentBrief · Not legal advice · patentbrief.org
US 12734225 · 2026